Our website is undergoing an update, so please apologize for any inconvenience. Our website is undergoing an update, so please apologize for any inconvenience. And stay tuned for the amazing news! ×

Our mission

is to serve greater longevity and prevent heart disorders for elevated heart risk groups through innovative and clinically proven predictive algorithms

Vision

The ultimate vision we have is to be an essential part of the population's health monitoring and heart disease prevention systems, providing the best prognostic tools for managing heart health and leading the prediction of cardiovascular diseases (CVD), chronic fatigue and burnout.

Values

We act on values of Health Sustainability, Innovation, Reliability and Collaboration to globally improve people's heart health.

Founders

Anna Starynska

Chief Executive Office

Has MS in Computer & Data Science and is an impeccable project manager with more than 25 years of experience in leading multinational complex projects, such as European Commission initiative for the 15 Nuclear Power Plants maintenance optimisation and the Global Tuberculosis Fund projects management. She is a natural leader, truly passionate about improving heart health, and a serial entrepreneur who bootstrapped the company with her life savings.

Read more

Illya Chaikovsky

Chief Science Officer

MD, multiple PhD with more than 25 years of practicing in cardiology. He's the globally-renowned scientist, whose invaluable experience gained at Institute of Cybernetics, the Ukrainian Academy of Science, his German Radgein University PhD work and multiple researches form the core of Cardiolyse CE-certified ECG processing algorithms and patents. Illya is leading an advisory PhDs in Cardiology, Cybernetics, Neural Networks and Data Science, that together with the development team are constanly improving and clinically validating our algorithms.

Read more

Timeline

Q2

Company launch

Q3

First algorithms finalized and web-platform developed

Q4

Oxford University and China Kadoorie Biobank ongoing validation project start

Q2

Patents for Method of ECG Evaluation Based on Universal ECG Scoring System filed

Q4

Ongoing pilot on CVD remote heart health monitoring in India start

Q4

Fatigue Risk Management proof of concept for liability insurance launched

Q2

Company brand update, Heart Health monitoring Android and iOS app update

Stay tuned for our news

Science

Austin Cardiology

Interrelation of the Level of Fatigue and the Parameters of the Energy Supply of Activity for Medical Workers

Read more

JACC

Adaptation of medical staff cardiovascular systems to night shifts working

Read more

IEEE Xplore

Investigation of the ECG leads sensitivity to Myocardial Ischemia by Means of Biophysical Model

Read more

Highlights

2019
CE certification
2019
Top-10 Ukrainian-UK startup contest winner
2018
Top-100 Startups at Slush, Finland
2018
Alumni of Startupbootcamp Digital Health, Berlin
2017
Seal of Excellence certificate from European Commission
2017
GE Healthcare Innovation Village Resident
2016
Selected participant of Novartis HealthTech Lab at Vivatech
2016
Selected participant at TechCrunch SF

Investment

We've successfully risen €500К for Cardiolyse initial platform developmen, market research and clinical trials, along with first successful pilots with world's key players from insurance and pharma sectors, hospital inpatient and outpatient units.

Read more

Cardiolyse has opened its last investment round now to grow exponentially, conduct cardiovascular researches of global value, maintain further clinical trials and develop more product features of patients' and healthcare providers' value while enhancing our team with the robust talent to tackle emerging challenges and receiving certifications for the next markets enter.

Find out more about Cardiolyse investment opportunities
to join the healthcare digital transformation movement and leave your lasting footprint in cardio diagnostics advancement

Let’s work together
on heart health improvement